Due to concerns surrounding COVID-19 and after significant discussion and consultation over the last week, CSA leadership has cancelled the Annual Meeting, scheduled for April 2-5 in San Diego.
A survey of anesthesiologists shows that insurers are abruptly terminating physician contracts, forcing many of the specialists out of network.
Note to CSA Members and Partners Preparing to attend CSA’s Annual Meeting in San Diego April 2-5 in regards to the Coronavirus (COVID-19), and considerations when traveling.
This letter was submitted on behalf of the CA Society of Anesthesiologists and Society for Pediatric Pain Medicine expressing concern about the regulatory proposal to list acetaminophen as a cancer-causing drug that requires Prop 65 labeling – thanks to Dr. Shah and Dr. Agarwal for their leadership on this.
Protecting consumer safety is an important part of government oversight, but a regulatory effort currently underway in California could actually pose more harm than good. There is debate over whether acetaminophen should be added to the Proposition 65 list, which serves as a warning to the public of cancer-causing chemicals.